EUROPEAN ASSOCIATION FOR CANCER RESEARCH
EACR202608-11 June 2026 Budapest
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| 35-EACR26 | Real world outcomes of immunotherapy for patients with endometrial cancer | Bethan Stanley |  Received |
 |
|||
| 54-EACR26 | Identification of Tim-3 in relation to Vγ9Vδ2T cell exhaustion in urinary bladder cancer | TERUKI SHIMIZU | Received |
|
|||
| 80-EACR26 | Targeted Hybrid Capture with Long-Read Sequencing Accurately Detects Large Structural Variants Using an Optimized Chemistry and a Simple Long-Read Analysis Pipeline | Markus Storbeck | Received |
|
|||
| 139-EACR26 | Alpha-synuclein-mediated immunological signatures in melanoma | Panagiota Filippou | Received |
|
|||
| 158-EACR26 | BQ323636.1 promotes Doxorubicin resistance in ER-positive breast cancer via IGF-1/PI3K/mTOR/GPX4 ferroptosis suppression | Ui Soon Khoo | Received |
|
|||
| 190-EACR26 | A high-fat prenatal environment and MYCN cooperates to drive neuroblastoma tumourigenesis through mitochondrial ATP synthase reprogramming | Rituparna Mittra | Received |
|
|||
| 212-EACR26 | Tumor Immunogenicity Unlocked: Multi-omics Models Predict Immunotherapy Response and Survival | Axel Gschwind | Received |
|
|||
| 220-EACR26 | RAF1 hotspot mutations S257L and S259F confer intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma | Yihang FU | Received |
|
|||
| 244-EACR26 | Prospective mapping of DNA variants modulating therapy response in cancer using gene editing | Matthew Coelho | Received |
|
|||
| 316-EACR26 | Study of the response to cytotoxic chemotherapy and targeted therapy in a cohort of patients with metastatic colorectal cancer using artificial intelligence-based networks | Marco Peluso | Received |
|
|||
| 335-EACR26 | Spatial transcriptomics reveals NGFR as a prognostic biomarker and translational target in high tumor budding triple-negative breast cancer | Rungdawan Wongsamart | Received |
|
|||
| 346-EACR26 | Multiplexed single-cell drug response profiling (4iDRP) for predictive precision oncology | Arpan Kumar Rai | Received |
|
|||
| 382-EACR26 | Therapeutic Targeting of Mutant p53–Driven UPR Addiction Overcomes ER Stress Resistance in Metastatic Prostate Cancer | Evangelos Pavlakis | Received |
|
|||
| 430-EACR26 | Differential ERK and AKT signaling plasticity underlies adaptive and genetic resistance to BRAFV600E inhibition in melanoma | Paolo Armando Gagliardi | Received |
|
|||
| 455-EACR26 | Therapeutic potential of targeting Processing-Bodies in Metabolic Dysfunction-Associated Steatohepatitis and hepatocellular carcinoma | Noémie Gellée | Received |
|
|||
| 466-EACR26 | Metrologically traceable quantification of NRAS p.Q61R by digital PCR | Jessica Petiti | Received |
|
|||
| 479-EACR26 | Analysis of data concordance across oncology patient-reported outcome measures (PROMs) | Ingeborg de Gooijer | Received |
|
|||
| 493-EACR26 | Fascin-1 Overexpression at Diagnosis is Independently Associated with Right-Sided Location and MSI-High Status in Colorectal Cancer: Results from the HITCLIF Clinical Trial Cohort | Antonio Asensi Cantó | Received |
|
|||
| 511-EACR26 | Waterpipe smoke activates protective autophagy in normal lung cells linking it to carcinogenic changes | Rania Zaarour | Received |
|
|||
| 591-EACR26 | Deciphering spatial heterogeneity of patient-derived organoids of colorectal tumors for drug discovery | Maxim Norkin | Received |
|
|||
| 597-EACR26 | Linking immunotherapy and congestive heart failure: a pharmacovigilance analysis | Aditya Lakkamsani | Received |
|
|||
| 604-EACR26 | Proliferative Capacity of Vδ1 T Cells Post-Expansion from Healthy Blood Donors | Amy Walsh | Received |
|
|||
| 682-EACR26 | Spatial and Single-Cell Profiling Identify Tfh Niches and CD8? Exhaustion as Drivers of Glofitamab Resistance in B-NHL | Paul Marcoux | Received |
|
|||
| 722-EACR26 | Microenvironment-dependent control of apoptosis through deep BCL2-family modulation in B-cell lymphoma | David Chiron | Received |
|
|||
| 735-EACR26 | The proteasome activator subunits PA28a and PA28b have distinct roles in glioblastoma | Kyle Heemskerk | Received |
|
|||
| 769-EACR26 | UNLOCKING VULNERABILITIES: BCL2 INHIBITORS TARGET BCOR-MUTATED AML | Sylvain Garciaz | Received |
|
|||
| 770-EACR26 | DNA methylation-based immune subtyping of esophageal adenocarcinoma | Rita Pinto | Received |
|
|||
| 775-EACR26 | Tissue Compartmental Characterisation of γδ T Cells Differentiates Cytotoxic and Inhibitory Receptor Expression in Colon Cancer | Karla OShea | Received |
|
|||
| 778-EACR26 | Store-Operated Calcium Entry Blockade Modulates Hypoxia-Induced Inflammatory Signaling and Migration in Glioblastoma Cells | Abdullah Alhamed | Received |
|
|||
| 780-EACR26 | Store-Operated Calcium Entry Enhances Pro-Tumor Crosstalk Between Macrophages and Breast Cancer Cells | Mohammed Alqinyah | Received |
|
|||
| 783-EACR26 | Crosstalk between DOT1L and the Mediator complex regulates glioblastoma stem cell growth | Samir Assaf | Received |
|
|||
| 809-EACR26 | A NOVEL LAB-ON-CHIP PLATFORM TO MODELING CANCER METASTASIS FOR DRUG DISCOVERY | Lutfiye Yildiz Ozer | Received |
|
|||
| 836-EACR26 | The Human Antigen R is a key determinant of cancer cells proliferation and adaptation to hypoxia in neuroblastoma. | Noemie Legrand | Received |
|
|||
| 860-EACR26 | A DNA Methylation-Based Algorithm Distinguishing Uterine Leiomyoma from Leiomyosarcoma: Tissue Discovery with Prospective cfDNA Translation | Edyta Biskup | Received |
|
|||
| 892-EACR26 | Differential KEAP1/NRF2 signaling widens therapeutic window of TXNRD1 inhibitors in SCLC therapy | Hana Nusková | Received |
|
|||
| 948-EACR26 | Machine Learning-Derived Proteomic Signatures of a Healthy Plant-Based Diet and their Mediating Role in Cancer Risk | Jihye Kim | Received |
|
|||
| 950-EACR26 | A senolytic ADC drives synthetic lethality and immune surveillance for senescent cancer cell destruction | Liqin Wang | Received |
|
|||
| 990-EACR26 | Lipid metabolism shapes ferroptosis susceptibility in AML | Maria Oundjian | Received |
|
|||
| 1017-EACR26 | Unlocking Same-Cell Biology: Non-Destructive Temporal Profiling and Precision Engineering via FluidFM® Technology | Ludovica Rizzo | Received |
|
|||
| 1022-EACR26 | High-Throughput Automated Organoid-Based Chemosensitivity Profiling Maps the Drug Response Landscape for Precision Oncology in Cholangiocarcinoma | Hui Bai | Received |
|
|||
| 1047-EACR26 | Rapid AI-Assisted Intraoperative Margin Assessment for Biliary Tract Adenocarcinoma Using Femtosecond Label-Free Microscopy | Tongxin Cao | Received |
|
|||
| 1118-EACR26 | Differential role of ATG7 isoforms in liver cancer development | Paula Fernández-Palanca | Received |
|
|||
| 1127-EACR26 | Calreticulin overexpression induces pro-tumoral features and molecular changes in dysplastic oral keratinocytes. | Nathalia Marques | Received |
|
|||
| 1147-EACR26 | Xenograft tissue slice tandem co-cultures as models for ex vivo analyses of glioblastoma invasion or brain metastasis | Achim Aigner | Received |
|
|||
| 1152-EACR26 | Ferroptosis in gastric cancer is affected by oncogenic ERBB3 via modulation of lipid peroxidation and GSH synthesis | Achim Aigner | Received |
|
|||
| 1176-EACR26 | Prognostic Significance and Functional Role of IL-17RC in Oral Squamous Cell Carcinoma | Bruno da Costa | Received |
|
|||
| 1179-EACR26 | Identification of cap methyltransferase 1 (CMTR1) as a HIF coactivator | Daiana Drehmer | Received |
|
|||
| 1209-EACR26 | Humanized immune system mice replicate cellular and molecular hallmarks of CRS | Iris Nkamba | Received |
|
|||
| 1219-EACR26 | Fully customizable humanized immune system mouse platforms for preclinical drug development | Iris Nkamba | Received |
|
|||
| 1223-EACR26 | Pdcd4–Rictor Interaction Suppresses PFKFB3 to inhibit Tumorigenesis | Qing Wang | Received |
|
|||
| 1231-EACR26 | Gene expression–based molecular subtypes associated with prognosis in Colombian colorectal cancer | Wendy Montero-Ovalle | Received |
|
|||
| 1238-EACR26 | Glioma Exosomes Mediate Systemic Immune Suppression Through Myeloid Cell Targeting | Emily Xu | Received |
|
|||
| 1259-EACR26 | PD-L1 expression predominates in immune cells over tumor cells in prostate cancer tissue from Mexican patients across Gleason Score categories | Jorge Adrian Ramirez de Arellano Sanchez | Received |
|
|||
| 1262-EACR26 | High aggressiveness prostate cancer cells decrease survival, proliferation, and differentiation processes in a GPER dependent manner | Jorge Adrian Ramirez de Arellano Sanchez | Received |
|
|||
| 1343-EACR26 | A First-in-Class Engineered Extracellular Vesicle Therapeutic Delivering miR-885-5p Targets the Metastasis Driver LCP-1 in Triple-Negative Breast Cancer | Marianna Prokopi | Received |
|
|||
| 1357-EACR26 | Overcoming Therapeutic Resistance in Non-Small Cell Lung Cancer via Covalent Engagement of EGFR Cysteine 775 | Richard Noble | Received |
|
|||
| 1362-EACR26 | PARP and USP1 inhibitor combination effects in in vitro models of ovarian cancer | Stella Breininger | Received |
|
|||
| 1474-EACR26 | Spatial organization and therapeutic vulnerabilities of drug-tolerant persister programs in HER2-positive breast cancer | Thanh Hoa Vo | Received |
|
|||
| 1571-EACR26 | Decoding Tumor Cell Invasive Switch | Maria John | Received |
|
|||
| 1747-EACR26 | Integrated Single-Nuclei and Spatial Transcriptomics at Scale Uncovers Clinically Relevant Heterogeneity in Malignant Pleural Mesothelioma | Krisztian Homicsko | Received |
|
|||
| 1758-EACR26 | A multi-tissue spatial atlas of coordinated gene expression during physiological adaptation | Lukas Paul | Received |
|
|||
| 1765-EACR26 | Quantitative Mapping of Protein–Protein Interactions During DNA Double Strand Break Repair | Elin Enervald | Received |
|
|||
| 1796-EACR26 | Spatial PD 1/PD L1 Interaction Profiling Across Immune Cell Populations Using a Unique Protein Proximity Assay and Simplified TSA IF Multiplexing | Mikael Malmqvist | Received |
|
|||
| 1797-EACR26 | Insights from orthotopic tumor engraftment in humanized immune system mice | Iris Nkamba | Received |
|
|||
| 1808-EACR26 | Analytical performance of a highly sensitive, distributable whole-genome sequencing (WGS) assay for molecular residual disease (MRD) detection research. | Yuan Ding | Received |
|
|||
| 1817-EACR26 | Preclinical efficacy, safety, and biodistribution assessment of therapeutic candidates with humanized mouse models | Iris Nkamba | Received |
|
|||
| 1853-EACR26 | Analytical Accuracy and Reproducibility of Illumina TruSight™ Oncology 500 v2 assay for Homologous Recombination Deficiency (HRD) evaluation and Comprehensive Genomic Profiling (CGP) | Andy Wang | Received |
|
|||
| 1869-EACR26 | Very Long Chain Fatty Acid Synthesis is a Metabolic Dependency and Therapeutic Target in NRAS Mutant Myeloid Leukemia | Rebecca Gelfer | Received |
|
|||
| 1921-EACR26 | Spatial proteomic profiling of metabolic and cell signaling heterogeneity in Breast Cancer tumor microenvironment using Imaging Mass Cytometry | Daniela Natale | Received |
|
|||
| 1923-EACR26 | Integrated spatial transcriptomic and proteomic profiling uncovers tumor-immune niches driving heterogeneity and resistance in Clear Cell Renal Cell Carcinoma | Daniela Natale | Received |
|
|||
| 1924-EACR26 | Deciphering Translational Insights from Mouse Model to Human Tumors Using Imaging Mass Cytometry | Daniela Natale | Received |
|
|||
| 1925-EACR26 | Integrating hematoxylin & eosin histology with multiplexed Imaging Mass Cytometry for spatial proteomic profiling of antibody-drug conjugate targeted biomarkers | Daniela Natale | Received |
|
|||
| 1926-EACR26 | A 61-Parameter CyTOF Panel for Comprehensive Profiling of Human PBMC to Characterize Immune Activation, Checkpoint Expression and Cytokine Signatures with Applications in Cancer Immunology | Daniela Natale | Received |
|
|||
| 1931-EACR26 | Novel Genetically Engineered Mouse Model of Ovarian Carcinosarcoma Reveals a Dual Role for Anti Inflammatory Drugs | Einav Girsh | Received |
|
|||
| 2004-EACR26 | High-Dimensional Characterization of Tertiary Lymphoid Structures | Ghislaine Lioux | Received |
|
|||
EACR2026
08-11 June 2026 Budapest
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 08/06/2026 TO 08/06/2026
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 19/05/2026
|
|
